Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
Assessing combined anti-platelet therapy in suspected acute myocardial infarction Aspirin has been shown to be effective in the emergency treatment of acute myocardial infarction. It irreversibly inhibits platelet cyclo-oxygenase and thereby prevents the formation of the platelet aggregating agent t...
1. autor: | Second Chinese Cardiac Study (CCS-2) Collaborative Group |
---|---|
Format: | Journal article |
Język: | English |
Wydane: |
2000
|
Podobne zapisy
-
COMMIT/CCS-2 Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study
od: Collins, R
Wydane: (2005) -
COMMIT/CCS-2 (Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study)
od: Chen, Z
Wydane: (2005) -
Gender difference in prognosis after acute MI among 45,852 Chinese patients in COMMIT/CCS2
od: Chen, Y, i wsp.
Wydane: (2009) -
ORAL CAPTOPRIL VERSUS PLACEBO AMONG 13634 PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION - INTERIM-REPORT FROM THE CHINESE CARDIAC STUDY (CCS-1)
od: Liu, L, i wsp.
Wydane: (1995) -
Social Acceptance of CCS
od: Atsuko TANAKA
Wydane: (2020-11-01)